Michael Tanaka
Impact in
- Gastroenterology top 0.5%
- Gastrointestinal Tumor Research and Treatment
-
- Gastric Cancer Management and Outcomes
- Sarcoma Diagnosis and Treatment
Papers in
- Oncology 11
- Colorectal Cancer Treatments and Studies 4
- Cancer Treatment and Pharmacology 3
- Lung Cancer Research Studies 3
- Cancer Immunotherapy and Biomarkers 2
-
- Lung Cancer Treatments and Mutations 5
- Gastric Cancer Management and Outcomes 3
- Co-authors
- Laurence H. Baker (1 shared paper)Cathryn Rankin (1 shared paper)George D. Demetri (1 shared paper)Charles D. Blanke (1 shared paper)John J. Crowley (1 shared paper)Robert G. Maki (1 shared paper)Robert S. Benjamin (1 shared paper)Margaret von Mehren (1 shared paper)
- Journals
- Journal of Clinical Oncology (5 papers)Investigational New Drugs (2 papers)Journal of Thoracic Oncology (2 papers)Cancer Investigation (2 papers)Journal of Immunotherapy (1 paper)
- Partner nations
- United StatesIndiaCanada
In The Last Decade
Michael Tanaka
19 papers receiving 1.9k citations
Michael Tanaka's Hit Papers
Peers
Comparison fields: 5 of 94
- Gastroenterology 629
- Pulmonary and Respiratory Medicine 767
- Oncology 582
- Neurology 207
- Surgery 576
Countries citing papers authored by Michael Tanaka
This map shows the geographic impact of Michael Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Tanaka more than expected).
Fields of papers citing papers by Michael Tanaka
This network shows the impact of papers produced by Michael Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Tanaka. The network helps show where Michael Tanaka may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Tanaka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033 Hit paper breakdown → | 2008 | 768 |
| 2 | 2001 | 480 | |
| 3 | 2009 | 225 | |
| 4 | 2006 | 111 | |
| 5 | 2020 | 98 | |
| 6 | 2007 | 33 | |
| 7 | 2002 | 29 | |
| 8 | 2004 | 27 | |
| 9 | 2016 | 25 | |
| 10 | 2014 | 24 | |
| 11 | 2007 | 19 | |
| 12 | 1991 | 19 | |
| 13 | 2010 | 12 | |
| 14 | 2006 | 11 | |
| 15 | 2003 | 6 | |
| 16 | Population-based maximum tolerated dose of irinotecan and carboplatin. | 2003 | 6 |
| 17 | 2016 | 4 | |
| 18 | 2008 | 1 | |
| 19 | 2011 | 1 | |
| 20 | 2007 | 1 |
About Michael Tanaka
Michael Tanaka is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Surgery and Pathology and Forensic Medicine, having authored 21 papers that have together received 1.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (5 papers), Colorectal Cancer Treatments and Studies (4 papers), Cancer Treatment and Pharmacology (3 papers), Lung Cancer Research Studies (3 papers), Gastric Cancer Management and Outcomes (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Cancer therapeutics and mechanisms (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Gastroenterology (629 citations), Pulmonary and Respiratory Medicine (767 citations), Oncology (582 citations), Neurology (207 citations) and Surgery (576 citations). Michael Tanaka has collaborated with scholars based in United States, India and Canada. Frequent co-authors include Laurence H. Baker, Cathryn Rankin, George D. Demetri, Charles D. Blanke, John J. Crowley, Robert G. Maki, Robert S. Benjamin, Margaret von Mehren, Ernest C. Borden and Michael C. Heinrich. Their work appears in journals such as Journal of Clinical Oncology, Investigational New Drugs, Journal of Thoracic Oncology, Cancer Investigation and Journal of Immunotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.